Bayer AG
featured
European shares closed higher on Monday after Italy's new Prime Minister announced his reform plans in his maiden speech to parliament.
» Read More
More
-
A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam products in cars.
-
A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam products in cars.
-
NEW YORK, May 15- Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased competition and reimbursement pressure.
-
*Risks include high valuation, competitive threats By Ransdell Pierson. TARRYTOWN, N.Y., May 7- Just two years ago, Regeneron Pharmaceuticals was a relatively obscure biotech company in the village of Tarrytown, a picturesque New York suburb better known for "Rip Van Winkle," "The Legend of Sleepy Hollow," and other creations of hometown author Washington Irving.
-
*Shares jump five-fold in two years, market value $26 bln. TARRYTOWN, N.Y., May 7- Just two years ago, Regeneron Pharmaceuticals was a relatively obscure biotech company in the village of Tarrytown, a picturesque New York suburb better known for "Rip Van Winkle," "The Legend of Sleepy Hollow," and other creations of hometown author Washington Irving.
-
FRANKFURT, May 6- A court ruled that Bayer. Schering investors who held a combined 7.5 million shares and did not accept the rival German drugmaker's offer of 89.36 euros per share in July 2006 are eligible to receive 124.65 euros, plus interest, for each share they held before Bayer took full control of Schering, law firm Dreier Riedel said.
-
FRANKFURT, May 3- Bayer said its HealthCare division stopped a Phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety concerns.
-
*Aiming to win bigger slice of growing market* Lilly currently No.4 in $40 bln diabetes market* Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt. FRANKFURT, May 3- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market.
-
*FDA advisory panel votes against approval of tivozanib. May 2- An advisory panel to the U.S. Food and Drug Administration recommended that the agency reject a kidney cancer drug made by Aveo Pharmaceuticals Inc and Astellas Pharma Inc, saying data from the clinical trial were inconsistent.
-
*Helvea raises price target to 84 euros from 82 euros; rating accumulate. For a summary of rating actions and price target changes on European companies:. Reuters Station users, click. 1580.
-
The Pleasanton, California- based company has hired Morgan Stanley and Deutsche Bank AG, the sources said on Tuesday. Veeva Systems, Morgan Stanley and Deutsche Bank declined to comment. It has more than 150 customers including large pharmaceutical companies like AstraZeneca PLC, Bayer, Eli Lilly& Co.
-
*FDA staff question sends Aveo shares down as much as 21.3 pct. April 30- Staff reviewers for the U.S. Food and Drug Administration will ask a panel of outside medical experts on Thursday whether another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc.
-
*FDA staff question sends Aveo shares down as much as 21.3 pct Staff wonder whether additional trial needed.
-
April 30- Staff reviewers for the U.S. Food and Drug Administration will ask a panel of outside medical experts if another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc and Astellas Pharma Inc can be approved.
-
*Analysts provide mixed interpretations of FDA review. April 30- Staff reviewers for the U.S. Food and Drug Administration have asked a panel of outside medical experts whether another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc and Astellas Pharma Inc can be approved.
-
*Analysts provide mixed interpretations of FDA review. April 30- Staff reviewers for the U.S. Food and Drug Administration have asked a panel of outside medical experts whether another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc.
-
European shares closed higher on Monday after Italy's new Prime Minister announced his reform plans in his maiden speech to parliament.
-
**ORCHARD SUPPLY HARDWARE STORES, $2.11, up 42 pct. Telular said it may solicit superior proposals from third parties through may 29, 2013. Germany's Bayer AG has agreed to buy the U.S. contraceptive devices maker for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider.
-
Germany's Bayer AG has agreed to buy the U.S. contraceptive devices maker for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider. **SINA CORP, $59.74, up 19 pct** YAHOO INC, $24.72, up 0.3 pct.
-
*Europe likely to impose ban after governments fail to agree. Europe is expected to impose a temporary ban on the pesticides after EU governments failed on Monday to agree whether or not their use should be halted.